UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Commonwealth Financial Services LLC

Commonwealth Financial Services LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 26.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,004 shares of the healthcare conglomerate’s stock after purchasing an additional 209 shares during the quarter. Commonwealth Financial Services LLC’s holdings in UnitedHealth Group were worth $508,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. First PREMIER Bank boosted its position in UnitedHealth Group by 7.0% during the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after acquiring an additional 18 shares during the last quarter. Genesee Capital Advisors LLC boosted its holdings in UnitedHealth Group by 1.9% during the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after purchasing an additional 18 shares during the last quarter. Jmac Enterprises LLC lifted its position in UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after buying an additional 18 shares in the last quarter. Powers Advisory Group LLC grew its holdings in shares of UnitedHealth Group by 4.8% in the 3rd quarter. Powers Advisory Group LLC now owns 418 shares of the healthcare conglomerate’s stock valued at $244,000 after acquiring an additional 19 shares in the last quarter. Finally, Wallace Capital Management Inc. raised its holdings in UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after acquiring an additional 19 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.1 %

UNH opened at $548.65 on Tuesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a market capitalization of $504.91 billion, a price-to-earnings ratio of 35.40, a P/E/G ratio of 1.48 and a beta of 0.61. The company has a 50-day simple moving average of $536.17 and a 200 day simple moving average of $565.20.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.53%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of several recent analyst reports. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Wells Fargo & Company reduced their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.